Background: Physician recommendation is one of the most important determinants of obtaining
Introduction
Colorectal cancer is the second leading cause of cancer deaths in the United States (1).
Multiple screening options are endorsed by the US Preventive Services Task Force (USPSTF) and the American Cancer Society. Effective implementation of the currently available screening tests could have a positive impact on the morbidity and mortality of tens of thousands of lives. However, just over 60% of eligible Americans receive CRC screening within the recommended time intervals (2) .
Prior research has consistently identified physician recommendation as one of the most important factors associated with the receipt of CRC screening (3, 4) . Making a clear and compelling recommendation for CRC screening is complicated by the availability of multiple modalities --each with different procedures, risks/benefits, costs and levels of unpleasantness-making the colorectal cancer screening decision-making process ripe for shared and informed decision making (5, 6) .
Informed decision making includes providing information about the nature of the procedure, alternatives and the risks and benefits of the alternatives (5) . Discussions with these informational elements are consistent with the screening recommendation approach from the USPSTF (6).
Efforts to improve the quality of the decision-making process must be responsive to patient information needs as well as their screening modality and shared decision-making preferences. While others have examined patient preferences for screening modality (7) (8) (9) (10) or test attributes (11) (12) (13) and the use of shared decision making (14), we are not aware of others who have examined different types of information about CRC screening that patients rate as important and the degree to which those key types of information are provided by their primary care physician during CRC recommendations. We compare patient ratings with actual physician communication of elements of information about colorectal cancer screening during periodic health exams. We also examine patients' use of questioning and whether their questions serve to fill gaps in information provision during these exams. 
Methods
The details of this cross-sectional observation study and the study participants have been described in detail elsewhere (14). Briefly, family medicine and internal medicine physicians from a large integrated health system in southeast Michigan were invited to participate. Physicians were informed that that this was a study about doctor-patient communication; they were not informed of the main study questions or specific hypotheses.
Patient participants included those aged 50-80 years who were due for colorectal cancer screening at the time they scheduled a routine annual physical exam with a study participating physician. Study participation included completion of a pre-visit telephone survey, audio-recording of the scheduled office visit and completion of a brief post-visit survey. Visits were audio-recorded using a small digital recording device placed in the exam room by a research assistant. The data were 
Data collection methods
The pre-visit telephone survey assessed patient demographic information and information relevant to cancer screening tests. The primary variables for this analysis assessed patients' rated importance of types of information about screening tests based in part on Braddock's recommendation for informed decision making (5) . The introduction to the question was as follows:
'There are many types of information that people may want to know before they decide to have a screening test. I'm going to read a list of different types of information.' Patients were asked to use a 7-point scale anchored by '1=very important' and '7=not at all important' to rate how important it is that they have information regarding: the screening purpose (i.e. disease addressed by screening), the prepare for the test"). We included an item about the manufacturer of the test to assess if patients discriminate across types of information they rate as very important. We report the proportion of patients who rated these types of information as 'very important.'
Analysis of the audio recording
The content of the patient-physician CRC screening discussion was obtained via office visit audio-recordings. All recordings were transcribed prior to coding and organized in Atlas.ti, a program to facilitate analysis of text data. To evaluate the delivery of the information elements a structured coding template was developed using a priori working definitions. Discussion of any two alternative tests (colonoscopy, fobt, sigmoidoscopy or barium enema) qualified as discussing test alternatives.
Discussion of any risks of a screening test and discussing any benefits of CRC screening was counted as discussing 'pros and cons.' Three trained research assistants coded the visits by listening to the audio-recordings while following the associated transcript. Inter-rater reliability was assessed by having approximately 10% of recordings (n=43) coded by all three assistants. The average inter-rater reliability for the items used in this analysis was kappa=0.82.
In addition to the information regarding the disease addressed by screening, test accuracy, test alternatives, the pros and cons of testing and the testing process, we assessed if the patient asked questions about colorectal cancer screening. Using a qualitative content analysis approach, a categorization scheme for patient questions was derived based on patterns observed among the first 50 instances. A study team member (SF) reviewed and revised the categorization after examining all of the patient questions; this categorization was reviewed by two others (JEL, TW) and discrepancies in sorting were discussed and resolved by consensus. Final categorization of patient questions included: screening logistics, process, purpose, alternatives, risks/benefits and other. 
Results
A total of 77 of the 163 physicians approached agreed to participate in the study (47% participation rate). Physicians agreeing to participate were on average 48 years old, 57% were female and 66% were internists. Participating physicians were similar on these characteristics to those who declined participation (14). Fifty percent of patients identified as eligible for the study agreed to participate. As shown in Table 1 , patient participants were on average 59 years old, 64% were female and 66% were white. Twenty-eight percent of patients had a high school degree or less and 40% reported some college or a two-year degree. Household income was $60K or greater for 55% of the sample. Patient participants were similar to non-participants in race and marital status, but were on average 2 years younger and more likely to be female (10) .
The proportions of patients who rated the information elements as 'very important' are reported in the second column of Table 2 . Prior to the observed visit, the large majority of patients reported that having information about the screening purpose, test accuracy, test alternatives, the pros and cons of testing and the testing process is very important when making preventive screening decisions. Few patients reported that information about the manufacturer of the test is very important (20%, data not shown). Among those reporting that information about the disease addressed by screening is very important, 58% (214/368) received this information during the visit. Receipt of information reported as important was lowest for testing pros/cons (n=14, 4%). These 14 visits included only those instances where the physician provided information about a both pro and con of screening; either a pro (n=62) or a con (n=22) was discussed in 84 (24%) of visits of those patients who rated that information very important. Receipt of information was also low for test accuracy (7%) and moderately low for test alternatives (29%). All of those who reported that information about the testing process was important received some information about that topic.
Physicians infrequently asked patients if they had questions pertaining to CRC screening (5%). However, 49% of patients asked an unprompted question about CRC screening. Across the 415 visits, a total of 270 CRC screening related questions were asked by patients. Among those who asked a question, the average questions per visit was 1.3 (stddev 0.7, range 1-5). Table 3 shows the topic and frequency of questions asked. Most frequent were patient questions about screening logistics such as questions about who is supposed to call to schedule the appointment, clarification about the need for a referral, and questions specific to which medical group locales offered screening colonoscopies. The next most common patient questions were about the testing process. Notably infrequent were questions to fill the gaps in information elements patients indicated were important, but not discussed by the physician. Specifically, only 29 patient questions pertained to testing pros/cons, 12 pertained to test alternatives, and none pertained to test accuracy. 
Discussion
The emphasis on the information elements for an informed decision for CRC screening is in part driven by the multiple modalities for screening that are available and endorsed, making CRC screening a complex decision (5). The vast majority of patients in this study reported that information about the disease addressed by screening, test accuracy, test alternatives, the pros and cons of testing and the testing process was very important to have when making a decision to be screened.
Our detailed evaluation of office visit audio recordings found that patient-physician discussions of CRC screening rarely included these informational elements with the exception of the testing process.
These findings provide actionable information to address the problem that information necessary for an informed decision is not being provided during primary care office-based discussions of CRC screening (15, 16) . In addition, we found that while patient questions occur in half of the visits, the questions posed by patients do not serve to fill the gap between patient expressed importance of information and physician provided information.
There are several potential explanations for the observation that patient-physician discussions of CRC screening rarely included key informational elements that patients indicate they want. First, many of the elements for informed decision making are germane to comparisons across screening options (e.g. pros / cons, accuracy). Like others (17), we found that CRC discussions tend to focus on colonoscopy and rarely involve discussion of alternatives. When only one screening modality offered, the relevance of some of the information elements may be perceived as low by the physician.
Second, discussing CRC screening alternatives and the accuracy, pros and cons, process, for each test during every discussion of CRC screening may be unrealistic when CRC screening is one of many prevention and health promotion topics recommended to be addressed during a health maintenance visit (18, 19) . Limiting the conversation about colorectal cancer screening to a single test Information gaps may adversely affect subsequent screening (20) . Others found that patient report of additional information they wanted about CRC screening but were unable to ask their physician were less likely to have been screened for CRC (21) . Interestingly, in our study, patient questions were common (almost 1/2 of the visits), however, questions were predominately about screening logistics (e.g. how to schedule the test and where to go to obtain the test) and the testing process (e.g. whether sedation is required, polyp removal, preparation for the test, and the frequency of testing). The questions asked by patients rarely addressed test alternatives, test accuracy or other topics that patients indicated as very important to guide a decision about a screening test prior to the observed visit. We do not know if these are the only topics about which patients wanted more information. But, it seems reasonable that a level of "readiness to screen" may be evident by the 
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